FAK activity sustains intrinsic and acquired ovarian cancer resistance to platinum chemotherapyCarlos J. Díaz Osterman, David D. Schlaepfer, Christine Jean et al.|eLife|2019Cited by 142
FAK activity sustains intrinsic and acquired ovarian cancer resistance to platinum chemotherapyCarlos J. Díaz Osterman, David D. Schlaepfer, Duygu Ozmadenci et al.|bioRxiv (Cold Spring Harbor Laboratory)|2019Cited by 21
Abstract 3812: FAK inhibition resensitizes platinum-resistant serous ovarian cancerL.M. Bean, David D. Schlaepfer, Florian J. Sulzmaier et al.|Cancer Research|2016Cited by 2
Author response: FAK activity sustains intrinsic and acquired ovarian cancer resistance to platinum chemotherapyCarlos J. Díaz Osterman, David D. Schlaepfer, Duygu Ozmadenci et al.|Unknown|2019Cited by 2